- Report
- January 2024
- 269 Pages
Global
From €6670EUR$7,309USD£5,481GBP
- Report
- March 2025
- 200 Pages
India
From €2352EUR$2,490USD£2,000GBP
- Report
- May 2021
- 50 Pages
China
From €2455EUR$2,600USD£2,088GBP
- Report
- March 2024
- 238 Pages
Global
From €7508EUR$7,950USD£6,386GBP
- Report
- February 2024
- 81 Pages
Global
From €3500EUR$3,970USD£3,081GBP
Piperacillin is a broad-spectrum antibiotic used to treat a variety of bacterial infections. It is a semi-synthetic penicillin, derived from the natural penicillin nucleus, and is often used in combination with other antibiotics. Piperacillin is effective against a wide range of Gram-positive and Gram-negative bacteria, including many of the most common pathogens. It is commonly used to treat urinary tract infections, skin and soft tissue infections, and respiratory tract infections.
The piperacillin market is a segment of the larger antibiotics market. Antibiotics are used to treat bacterial infections, and the market is driven by the increasing prevalence of bacterial infections, as well as the development of new antibiotics to treat drug-resistant bacteria. The market is also driven by the increasing demand for antibiotics in the veterinary sector.
Some companies in the piperacillin market include Pfizer, Merck, Sanofi, GlaxoSmithKline, and AstraZeneca. Show Less Read more